Use of Bevacizumab in Metastatic Colorectal Cancer: Report from the Mexican Opinion and Analysis Forum on Colorectal Cancer Treatment with Bevacizumab (September 2009)

Author： Zinser-Sierra Juan W.  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.11, Iss.2, 2011-06, pp. : 101-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab: A Review of its Use in Metastatic Colorectal Cancer

By McCormack Paul L.   Keam Susan J.  

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 487-506

Adis International

Access to resources Recommend Favorite

Bevacizumab in colorectal cancer: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 5, 2005-05 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Role of the Antiangiogenic Agent Bevacizumab in the Treatment of Elderly Patients with Metastatic Colorectal Cancer

By >   Pietrantonio Filippo   Martinetti Antonia   Buzzoni Roberto   Gevorgyan Arpine   Bajetta Emilio  

Drugs & Aging, Vol. 28, Iss. 2, 2011-02 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

Vascular biology support for the use of bevacizumab in colorectal cancer

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 6, 2004-06 ,pp. : 703-705

Informa Healthcare

Access to resources Recommend Favorite

Case-Report: Folfoxiri Plus Bevacizumab in “Poor-Risk” Liver-Only Metastatic Colorectal Cancer: Case Report and State-of-the-Art

By  

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. : 78-83

Bentham Science Publishers

Access to resources Recommend Favorite